Abstract
This review summarizes important advances in polymer-based nanotechnologies for the treatment and diagnosis of cardiovascular diseases, focusing on nanoparticles and nanostructured materials/devices. The current state of the art and design parameters are discussed with the aim of providing a source of information that can aid in the development of new treatments by bridging between materials development, preclinical, and clinical trials. This is highly relevant as cardiovascular diseases remain a leading cause of death worldwide and as current treatments burden the healthcare systems with great costs. Different strategies, from targeting theranostic nanocarriers, to dual-drug depot systems, injectable cell scaffolds, and LDL acceptors are treated. The review ends with a concluding outlook on the possibilities and challenges presented to polymer-based nanotechnologies in cardiovascular disease therapy.
Original language | English |
---|---|
Pages (from-to) | 153-178 |
Number of pages | 26 |
Journal | Progress in Polymer Science |
Volume | 57 |
DOIs | |
State | Published - 1 Jun 2016 |
Keywords
- Cardiovascular diseases
- Drug delivery
- Nanoparticles
- Nanostructured
- Polymers
- Theranostic